SEC Form 4 · accession 0001123292-16-002337
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randall Mack
Officer — Senior VP, Development
Period of report
May 23, 2016
Accepted (ET)
May 25, 2016 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 23, 2016 | P | 2,000 | $6.30 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.